We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MFS
351
MSI Financial Services
Massachusetts
$11K +$9.94K +135 New
FHB
352
First Hawaiian Bank
Hawaii
$11K +$10K +136 New
BFEC
353
Benjamin F. Edwards & Company
Missouri
$10K +$9.65K +131 New
CIM
354
Contravisory Investment Management
Massachusetts
$9K +$8.1K +110 New
BWM
355
Baystate Wealth Management
Massachusetts
$8K +$7.36K +100 New
CA
356
CapWealth Advisors
Tennessee
$8K +$7.36K +100 New
CTC
357
Central Trust Company
Missouri
$8K +$7.36K +100 New
PMFA
358
Plante Moran Financial Advisors
Michigan
$8K +$7.36K +100 New
SSG
359
Summit Securities Group
New York
$8K +$7.36K +100 New
EFSCE
360
Enterprise Financial Services Corp (EFSC)
Missouri
$8K +$7.44K +101 New
ST
361
Smithfield Trust
Pennsylvania
$8K +$7.51K +102 New
PAS
362
Partnervest Advisory Services
California
$7K +$6.55K +89 New
AC
363
Alexandria Capital
Virginia
$6K +$5.16K +70 New
WRM
364
Westport Resources Management
Connecticut
$6K +$5.3K +72 New
WCBA
365
Weaver C. Barksdale & Associates
Tennessee
$6K +$5.45K +74 New
AF
366
Arrow Financial
New York
$5K +$4.42K +60 New
LWA
367
Lenox Wealth Advisors
New York
$5K +$4.71K +64 New
Bessemer Group
368
Bessemer Group
New Jersey
$4K +$3.68K +50 New
WA
369
WealthTrust-Arizona
Arizona
$4K +$3.68K +50 New
TSW
370
Thompson Siegel & Walmsley
Virginia
$4K +$3.98K +54 New
CFA
371
Carroll Financial Associates
North Carolina
$4K +$4.42K +60 New
TIM
372
Tortoise Investment Management
New York
$3K +$2.95K +40 New
ECAM
373
East Coast Asset Management
Massachusetts
$2K +$1.47K +20 New
WA
374
WFG Advisors
Texas
$2K +$1.47K +20 New
CAW
375
Cornerstone Advisors (Washington)
Washington
$2K +$1.62K +22 New
12 13 14
15
16

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.